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ABSTRACT
The pursuit of more suitable drugs intended for possible biological applications are a
continuously growing topic of research within the scientific community. One of these suitable
qualities includes the need for hydrophilicity and or some appropriate delivery system for the
drug to enter into biological systems. A system of analyzing and following these compounds
would then, however, be necessary to conduct any kind of mechanistic or interaction studies for
the said drug within the biological system. Just to name a few, fluorescence and X-ray computed
tomography (CT) methods allow for imaging of biological systems but require the need of
compounds with specific qualities. Finally, even with a means of entering and following a
loaded drug, it would not be complete without a way of targeting its intended location.
Herein, the first chapter reports the synthesis and characterization of a fluorene-based
pyridil bis-β-diketone compound with suitable one- and two-photon fluorescent properties and its
encapsulation into Pluronic F127 micelles for the possible application of tracking
lysosomes. Next the synthesis and characterization of a BODIPY-based fluorophore with
excellent fluorescence ability is reported.

This compound was conjugated to two

triphenylphosphine (TPP) groups and is shown as a potential mitochondria probe within HCT116 cells. Finally, the synthesis and characterization of diatrizoic acid (DA) based derivatives
conjugated to silica nanoparticles, as well as unconjugated, are reported as potential CT contrast
agents. The derivatives were also functionalized with maleimide moieties facilitating subsequent
potential bioconjugation of a targeting protein via a thiol group.
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CHAPTER 1. PHOTOPHYSICAL CHARACTERIZATION OF AND
BIOIMAGING WITH A NEW FLUORENE-BASED PYRIDYL
DIFLUOROBORON β–DIKETONATE
1.1 Abstract
A fluorene-based pyridil bis-β-diketone was derivatized with BF3 to form a cyclic
dinuclear difluoroboron complex. The photophysical properties of the boron complex were
investigated experimentally for its linear and nonlinear characteristics. The results revealed a
compound with absorption and emission falling within the biological imaging window with a
reasonable two-photon absorption (2PA) cross section. Additionally, one-photon and two-photon
fluorescence microscopy imaging of HCT-116 cells incubated with this difluoroboron complex
in both isolated form and encapsulated with Pluronic F127 micelles revealed the potential for use
of this molecule as a biological probe.
1.2 Introduction
1.2.1 One and Two-Photon Absorption, Fluorescence, and Microscopy
Two-photon absorption (2PA) is a nonlinear process that involves the unusual capability of
some molecules to absorb two photons near simultaneously in order to populate an energy level
within the molecule with energy equal to the sum of the energies of the two photons absorbed.1
A simple Jablonski diagram is shown in Figure 1-1 to offer a summary of this process. In the
diagram, line “a” shows the absorption of a single photon that contained enough energy for an
electron to be excited from the ground (S0) state to that of the excited state (S1). Line “b”
however shows the absorption of two lower energy photons, denoted by the shorter arrows and
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red color, and followed by non-radiative relaxation (curved cyan lines) to line “c”, which
represents the radiative emission of a photon denoted as fluorescence. In order for the process of
line “b” to occur, the absorption of the two lower energy photons would need to occur nearly
simultaneously, within the femtosecond time domain.

This is due to non-radiative decay

processes occurring within the nanosecond time domain and, thus, the absorption of the second
photon must occur before these processes dissipate the energy brought on by the first photon.

Figure 1-1. Simplified Jablonski diagram showing the one and two-photon absorption process
along with fluorescence.

2PA-based chromophores have been studied extensively because of their utility and
potential in multiple applications such as nondestructive two-photon fluorescence imaging,2-9
two-photon optical power-limiting devices,10-12 3D data storage,13-15 and two-photon
photodynamic therapy.16-18 It also is rapidly becoming an important tool in the fluorescence
microscopy of thick tissues and in vivo imaging. The advantages of this technique have been
demonstrated over conventional confocal microscopy;19 these benefits include increased
penetration depth and localized excitation that leads to greater contrast.6 This method is denoted
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as two-photon fluorescence microscopy (2PFM) and has been widely used in bioimaging of cells
and tissues. Its advantages over one-photon microscopy include the exclusion of incident light
absorption due to its ability to create only localized excitation. This effect is caused by what was
mentioned earlier as the near simultaneous absorption of two photons. By doing so, for the
production of the same excitation wavelength at the focal point, 2PFM can use two photons that
are roughly twice the wavelength of what a one-photon microscope would use to excite the same
fluorophore, and is shown in (Figure 1-2).20

Figure 1-2. One and two-photon microscopy comparison.

In addition, 2PFM applies longer wavelength, in the near-infrared (NIR) region for
excitation, relative to conventional confocal microscopy. Compared with visible light, biological
materials undergo less absorption in the NIR region, resulting less scattering and absorption and
deeper penetration in tissues. As a result, 2PFM is also suitable for deep tissue penetration 3D
bioimaging.
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1.2.1.1 Quantification of One- and Two-Photon Fluorescence
Fluorescence is a process that is dependent on many variables. This dependence on varying
conditions then calls for an efficient method of measuring and comparing the ability of different
fluorophores. Therefore the fluorescence quantum yields (Ф) of different fluorophores are
measured which relates the fluorescence emission ability of a material to a reference compound.
Equation 1 shows the calculation where Ф is the fluorescence quantum yield, OD is the optical
density at the excitation wavelength, I is the integrated fluorescence intensity, and n is the
refractive index of the solvent.21
(

)(

∫

∫

)(

)

(1)

The measurement of I in Equation 1 can simply be calculated by using the Beer-Lambert law
(Equation 2), which describes the OD of a molecule and is linearly dependent with concentration
(c in mol dm-3), extinction coefficient (ε in dm3 mol-1 cm-1), and path length of the sample (l in
cm). This behavior is different to that of two-photon absorption, which can be calculated by
using Equation 3 where σ2 is the 2PA cross section, NA is the number of photons absorbed per
second (photon s-1), and z is the position of the beam with respect to the focal point of the beam
equaling zero ( z = 0 = z0) using the z-scan method.22-23

(2)

(3)
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1.2.2 Importance of lysosome tracking in biological systems
Lysosomes are membrane-bound organelles found in eukaryotic cells meant for the
degradation of unwanted components within the cell. Lysosomes can play a role in a number of
physiological processes such as plasma membrane repair24-25 as well as bone and tissue
remodeling.26 Tumor metastasis can also be largely affected by alterations to normal lysosome
activity with shown effects on cell death and autophagy.27 The specific roles of lysosomes in
these processes still remain a subject of research that leads to the need of developing specific
lysosome probes.

Lysotracker Red is a commercial probe for tracking lysosomes that is

available through Life Technologies and is used as a standard for lysosomal imaging in many
cases.28-29 The commercial probe however fails to show any significant 2PA and, thus,
necessitates the further development of a 2PA lysosome probe.
1.2.3 Pluronic Micelle Encapsulation
The use of specialized dye/drug transporting systems has been studied extensively in
recent years.

These studies include the encapsulation or conjugation of compounds with

nanoparticles30, polymers,31 microemulsions and micelles.32 Recently, the use of Pluronic, a
poloxamer containing poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEOPPO-PEO), has been used in a number of studies involving the encapsulation and delivery of
drugs and dye33-35. It was also reported that Pluronic encapsulation of hydrophobic compounds
could greatly enhance their hydrophilicity as well as targeting ability to lysosomes 36.
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A

representative image of a poloxamer micelle is shown in Figure 1-3b along with a representative
image of a single poloxamer unit in Figure 1-3a.

Figure 1-3 Representative poloxamer monomer (a) and micelle (b).

The polypropylene unit of the poloxamer acts as the hydrophobic portion when multiple
units aggregate together while the polyethylene portions act as the hydrophilic portion. This
behavior makes it possible for hydrophobic compounds to be contained within the internal region
of the micelle.37
1.2.4 Colocalization and Pearson’s coefficient
In bioimaging, one common method of tracking internalized compounds during in vitro
or in vivo imaging is by colocalization. For fluorescence imaging this is normally done by
collecting the fluorescence signal of two or more separate compounds in different channels,
followed by an overlay of these channels into one. This method requires the spectral profile for
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each of the compounds imaged whose emission profiles differ enough to enable the
instrumentation to resolve the signals. Common examples of these are commercial dyes FITC
and TRITC whose spectral profiles differ enough to where the collection of one channel’s signal
would not overlap the other if the appropriate filters were employed. Then if the experiment
required the knowledge of whether a compound interacted with a particular target or not, one
would be able to conjugate a reference compound known to localize with that of the intended
target with, e.g., FITC while conjugating a compound of interest to, e.g., TRITC and coincubate
the two into the system. The appropriate form of microscopy to collect the fluorescence signal
from the two channels then follows this and the colocalization can be quantified using Pearson’s
correlation coefficient (PCC). PCC is a measure of linear correlation between two variables that
was originated by Galton38 in 1880 but was later named after his colleague Karl Pearson.39 Its
range of value lies between -1 to 1, where -1 is total negative correlation, 1 is total correlation,
and 0 is no correlation. The calculation of this can be seen in Equation 4, which uses
conventional naming where R represents the first channel and G for the second (also known as
Red and Green channel).40 The PCC is available in many image-processing software packages,
one of which is the open-source freeware imageJ, and is used in the calculation of this
experiment.41

∑(
√∑(

)(
) ∑(

)

(4)
)
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1.2.5 Development of fluorescent probe for lysosome targeting
Highly conjugated organic molecules consisting of a push-pull dipolar nature constitutes
the most extensive class of compounds that are investigated for nonlinear properties. These
chromophores usually involve electron donor and acceptor groups interacting through πconjugated spacers. Modulating the degree of ground-state polarization or the degree of charge
separation in the ground state of these molecules causes significant influence over their
molecular polarizability and hyperpolarizabilities.42-43 This charge separation in the ground state
can be controlled primarily by either modifying the chemical structure, i.e., altering the strength
of the donating and accepting substituents, and/or by extending the π-conjugated path.44-47
Many boron-containing materials possess impressive optical properties. Luminescent
difluoroboron complexes such as boron-dipyrromethenes (BODIPYs)48 and BF2-β-diketonates
(BF2bdks)49 usually possess high fluorescence quantum yields, and exhibit large extinction
coefficients and 2PA cross section values,50 making them promising candidates for optical
imaging and sensing applications. BODIPY derivatives are commercially available from
Invitrogen as molecular probes, sometimes functionalized to react with peptides and proteins for
immunostaining.
Lesser known are the BF2bdks whose potential has yet to be fully exploited for biological
applications. Borondiﬂuoride β-diketonates containing aromatic moieties in the chelating ring
were demonstrated as two-photon fluorescent probes for in vivo studies with the excitation in the
relative transparency window of tissues.49, 51-52 Conjugation of boron to a diketonate inhibits
nonradiative dissipation through O-H stretching modes from tautomerization between ketone and
enol structures by the formation of stable six-membered boron-chelating rings; these boron
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complexes retain unique characteristics of their diketonate fluorophore such as high fluorescence
quantum yield and high photostability.53-55 With these considerations in mind compound 2,
which can be seen in Scheme 1-1, was prepared and fully characterized with the intention of
exploring its possible bioimaging applications. The dye would be tested first independently
followed by the use of a Pluronic encapsulating agent. These experiments would then be imaged
using confocal microscopy and two-photon fluorescence microscopy on human colon rectal
cancer (HCT-116) cells.
1.3 Materials and Methods
1.3.1 Cell Culture and Incubation
HCT-116 epithelial colon rectal carcinoma cells were incubated at 37 °C with RPMI
media which was supplemented with 10% fetal bovine serum (FBS), 1% of streptomycin and
penicillin in a 95% humidified atmosphere containing 5% CO2. 2.5×104 cells were seeded onto
12 mm coverslips, which were functionalized with poly-D-lysine for 2 h. The treated coverslips
were then placed into a Costar clear-bottomed 24-well plate and incubated under the above
conditions for a period of 2 days. Seeded coverslips were incubated with either DMSO dye
solution or Pluronic F-127 encapsulated dye solution using RPMI medium, which also contained
Lysotracker Red (Invitrogen). Control slides containing dye solution or encapsulated dye
solution absent of Lysotracker Red were also prepared. Coverslips were then incubated for a
period of 2 hours. Dye solutions were extracted and the cells were washed abundantly with PBS
and fixed with 4% paraformaldehyde PBS solution for 10 min. Fresh solutions of (1 mg/mL)
NaBH4 solutions were prepared with PBS and three drops of 6 M NaOH to treat the fixed cells in
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order to reduce any autofluorescence that may occur due to the fixing agent. Finally the seeded
coverslips were then mounted onto microscope slides with Prolong Gold (Invitrogen) as a
mounting media.
1.3.2 Confocal One-photon and Two-photon Fluorescence Microscopy
Images were all recorded with a Leica TCS SP5 II laser-scanning confocal microscope system
with a 63× objective (HCX Pl APO CS 63.0 × 1.20 WATER UV). Confocal one-photon
fluorescent images were taken at 451, 463, and 488 nm excitation wavelengths and emission was
collected between 500-600 nm. Confocal one-photon fluorescence images of Lysotracker Red
were obtained at excitation wavelength 561 nm and emission was collected between 600-700
nm. Two-photon fluorescence images were recorded using the same Leica microscope system
coupled to a tunable Coherent Chameleon Vision S (80 MHz, mode-locked, 75 fs pulse width,
tuned to 900 nm).
1.3.3 Particle Size
Particle size data was obtained with a Zetasizer Nano ZS90, by using Pluronic F-127
encapsulated dye solutions filtered with 1.0 and 0.45 µm polyethersulfone membrane filters with
polypropylene housing.
1.3.4 Cytotoxicity Assays in Cells
HCT-116 cells were prepared for cell viability studies by seeding cells into Costar clear
bottom 96-well plates (5×103 cells per well) which were incubated for 48 h at 37 °C in RPMI.
DMSO dye solutions of varying concentrations were prepared with media and were incubated
for 24 h before 20 µL of MTS assay was added into each well for 2 h at 37 °C. Pluronic F-127
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encapsulated dye solutions were prepared in a similar manner except the incubation time of the
encapsulated dye solutions was for 4 h before the addition of MTS assay. Viability was
determined by measuring the MTS-formazan absorbance at 490 nm. Viability calculations were
then completed by comparison with controlled samples of no dye as well as dye samples of the
varying concentrations absent of cells.
1.3.5 Encapsulation of 2 in Pluronic F-127
Dye encapsulated Pluronic solutions were prepared by placing equal volumes of Pluronic
F127 stock solution (2.5 mg/mL) and 2 in hexane solution (40 µM), followed by stirring at 60 ⁰C
until the evaporation of the hexane was complete. The mixture was filtered through a Whatman 2
μm pore size disposable filter.

1.4 Results and Discussion
1.4.1 Synthesis of Compound 2
The synthesis of bis-difluoroboron 3,3'-(pyridine-2,6-diyl)bis(1-(7-(diphenylamino)-9,9dihexyl-9H-fluoren-2-yl)propane-1,3-dione) (2) is shown in Scheme 1-1.
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Scheme 1-1 Synthesis of bis-difluoroboron 3,3'-(pyridine-2,6-diyl)bis(1-(7-(diphenylamino)-9,9dihexyl-9H-fluoren-2-yl)propane-1,3-dione) (2).
1.4.2 Linear Photophysical Characterization
The UV-vis absorption spectrum of the bis-diketonate 1 exhibited two main absorption bands
(Figure 1-4), at λmax of 325 and 425 nm in hexane with a molar absorption coefficient of 65×103 M-1
cm-1. On ligating to boron diflouride, a significant red shift was observed in these bands to λmax of
350 and 550 nm respectively. This exceptionally large bathochromic shift, >125 nm in the longer
wavelength band was accompanied by a decrease in the molar absorption coefficient to ~ 55×103 M1

cm-1. This is suggestive of increased effective π-conjugation between the flourenyl and pyridyl

groups via the BF2-chelating moiety. A broad emission exclusive to non-polar solvents was observed
at λmax 567 nm in the case of hexane. Radiationless relaxation of the excited compound is effectively
retarded in polar solvents. It is believed the solvent to accommodate this molecule expends
considerable energy in solvent reorganization. Achieving this excitation energy realizes a lower
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probability of maintaining an emission (Figure 1-5). The sensitivity of the emission to polarity
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makes this compound an exciting prospect as a polarity probe.56
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Figure 1-4 Absorption (solid line) and emission (dashed line) spectra for 1(black) and 2 (red) in
hexane.
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Figure 1-5 Absorption (toluene in black, THF in blue) and emission from toluene solution (red;
dashed line λex = 368 nm; solid line λex = 517 nm) spectra for 2.
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The observed decrease in quantum yield with increased polarity is consistent as the solvent is varied
from hexane and cyclohexane to toluene (Table 1).

Table 1 Photophysical data for 2 in solvents of varying polarity.
εc

b

a

3

Φf d

-1

ΦPh

FM

/10-6

/106 GM

/nm

/nm

/nm

/10 M
cm-1

Hex

361, 502

418, 567

57, 65

55, 50

0.91

12

50

CHX

363, 509

425, 573

62, 64

58, 51

0.84

2.7

197

Tol

368, 517

450, 644

82, 127

49, 56

0.39

0.97

250

DCB

375, 544

484

109

54, 47

-f

0.65

-f

DCM

371, 535

482

111

41, 36

-f

1.1

-f

THF

366, 516

452

86

52, 47

-f

5.6

-f

Italicised values relate to shorter wavelength features. a Absorption and emission maxima ±1 nm;
Stokes shift ±2 nm;

c

extinction coefficients ±5%;

d

fluorescence quantum yields ±10%;

f

b

not

determined.
1.4.3 Nonlinear Characterization
Two-photon absorption spectra of 2 were recorded in toluene and THF at room temperature
using the open aperture z-scan measurements57. Figure 6 displays the spectra together with the
corresponding single-photon absorption and fluorescence emission spectra for both solvents. The
position of the two-photon absorption maximum (λ2PAmax) and the peak two-photon absorptivity
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maximum (σ2PA) satisfactorily match with twice the corresponding values of linear absorption
λ1PAmax; this suggests that the same excited states are reached regardless of the excitation mode.
However, these results were not anticipated given the symmetrical nature of the molecule.58
The 2PA spectrum is shown to be independent of solvent polarity, as this data shows
good overlap across the two solvents. The maxima at 1040 nm show a good 2PA cross section (~650
GM) in both toluene and THF. These peaks coincide with the main linear absorption band, a region
where the excitation anisotropy plateaus, suggesting that although this band represents more than
one electron transition.
2PA wavelength /nm
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Figure 1-6 Absorption (toluene, black; THF, red), emission (toluene, blue), excitation anisotropy
(silicone oil, dark green), and two-photon absorption (toluene, dark red; THF, dark blue) spectra
for compound 2.

Using the data obtained from the two-photon absorption spectra, the figure of merit, FM, can be
calculated for 2 across the solvents used through equation 2, where Φf is the fluorescence quantum
yield, δ is the maximum two-photon cross-section, and ΦPh is the photodecomposition quantum
yield.19
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(5)
Although the two-photon absorption spectra were only recorded in toluene and THF, the maxima
of the spectra were within experimental error of one another. As such the average of the maxima
was used in to calculate FM for hexane and cyclohexane (Table 1). These values show a marked
advantage over the Lysotracker Red dye, for which FM is 4 × 10-5 GM.59
1.4.4 In Vitro Studies
1.4.4.1 Cellular uptake of independent dye studies
On the basis of its observed photophysical properties, 2 appeared to be a suitable
candidate for further investigation as a potential probe for bioimaging. These include ideal
excitation and emission wavelength in the biological window, high fluorescence quantum yields
ΦF in non-polar solvents, and two photon absorption cross section of σ2PA ~600 GM in THF and
toluene. The following in vitro experiments, MTS assay for cytotoxicity60 and subcellular
localization imaging with Lysotracker Red was used in conjunction with both single and twophoton imaging experiments to evaluate the application of this compound for bioimaging using
both isolate and Pluronic micelle encapsulation. For this experiment investigation into the
cellular uptake properties was conducted per incubation of 2 with (colon rectal cancer cells)
HCT-116. The subcellular localizations of 2 were determined by costaining experiments using an
organelle-specific tracker. Confluent cells were coincubated with 2 and Lysotracker Red for 2
hours. Resulting images showed reasonable amount of overlay with lysosomes (Lysotracker
Red).61-62 Figure 1-7c shows the colocalization image of 2 and Lysotracker Red with the yellow
portions being the colocalized areas, green being the dye (Figure 1-7a), and red representing
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Lysotracker Red (Figure 1-7b). A moderate Pearson’s correlation coefficient value of 0.70 was
obtained for the isolate, using ImageJ calculation for colocalization behavior.19, 59, 63

Figure 1-7 One-photon fluorescence images of 2 coincubated with Lysotracker Red in HCT-116
cells. a) Excitation at 488 nm. b) Excitation at 561 nm. c) Overlay image. Scale bar 50 µm.
1.4.4.2 Preparation and Characterization of Pluronic Micelle
In order to improve the hydrophilic ability of 2, the encapsulation of 2 in Pluronic F127 was
conducted. Fluorescence quantum yields trended higher in non-polar environments, which gave the
incentive to use a hexane solution of 2 encapsulated with Pluronic as the delivery vehicle for the dye.
Optical properties of 2 in hexane as well as after Pluronic F127 encapsulation were studied using
UV-vis and fluorescence spectroscopy. These results can be seen in Figure 1-8.
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Figure 1-8 Absorption emission spectra of 2 before and after Pluronic F127 encapsulation.

A hypsochromic shift on the absorption λmax from 500 to 422 nm, as well as on the emission λmax
from 566 to 536 nm was observed. This is contributed to the change in the microenvironment of the
dye structure as the micelles are formed.64 Micelle sizes were recorded using dynamic light
scattering (DLS). As shown in Figure 1-9, the size of the micelles after encapsulated had a range
between 100 nm to 2 µm. Desired sizes were then chosen by using a particle size exclusion filter or
dialysis after production.
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Figure 1-9 Particle sizes of 2 encapsulated in Pluronics F127. T1, T2 and T3, represent three
trials of preparing the encapsulated dye in micelle.
As a potential probe for biological imaging the cytotoxicity of the 2 was evaluated using an MTS
assays in which the dose dependence of surviving cells after exposure to the Pluronic
encapsulated dye was assessed.60 The HCT-116 cells were exposed to various concentrations
(calculated via the extinction coefficient) of 2 in Pluronic by incubating 1 µm filtered particles
over various time periods within a Costar clear bottom 96-well plate, followed by viability
assays as can be seen in Figure 1-10. An incubation period of 4 h was selected in which viability
results showed values above 80% at 5 µM, a higher concentration than that employed to produce
the images.
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Figure 1-10 MTS assay results of 2 encapsulated in Pluronic F127 incubated for 4 hours in
HCT-116 cells.
1.4.4.3 Fluorescent imaging of 2 encapsulated in Pluronic F127
HCT-116 cells were incubated with probe 2 encapsulated in Pluronics F127 (5 μM) and
excited at 902 nm, where the dye showed a σ2PA of ~600 GM. Figure 1-11 shows the one-photon
and two-photon fluorescence images of these cells where clear fluorescence images of the
stained cells was obtained. One-photon fluorescence images of 2 encapsulated in Pluronic F127
(Figure 1-11a) not only showed the ability of colocalization with Lysotracker Red (Figure 111b) but also showed a higher Pearson’s coefficient value of 0.91 compared to 0.70 that was
obtained with unencapsulated 2. The two-photon fluorescence image (Figure 1-11c) also showed
a 0.90 Pearson’s coefficient with the Lysotracker Red channel, clearly supporting specific
localization of the probe 2 in the lysosomes by 2PFM. These values are both higher than the 0.85
Pearson’s coefficient obtained from the overlay of Figure 1-11c with Figure 1-11b.
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Figure 1-11 HCT-116 cells incubated with 2 encapsulated in Pluronic F127 and LTR in. (a)
One-photon fluorescence, excitation at 488 nm. (b) One photon fluorescence excitation at 561
nm. (c) Two-photon fluorescence excitation at 902 nm, scale bar 50µm.
To further study the colocalization behavior of the dye with Lysotracker Red intensity
profiles using regions of interests (ROIs) was employed using the Leica software platform
(LASAF). Linear regions were isolated and signal intensities investigated through different
channels. The signal intensities were mapped out according to three ROIs through the three
different channels (561 nm Lysotracker Red, 488 nm 2 (one-photon fluorescence) and 902 nm 2
(two-photon fluorescence)) seen in Figure 1-12 with their respective signal intensity profiles in
Figure 1-13. Also in Figure 1-13 the general trend of the signals superimposed on each other
showed that there is fluorescence within the same area throughout the three channels. It can be
observed that signal areas, which contain only signal from the Lysotracker Red channel are
apparent and that at those positions the signal from both the dye in one-photon fluorescence and
two-photon fluorescence channels are absent as seen in the circled portion of ROI 2 (Figure 113b). However, in ROI 3 (Figure 1-13c) the intensity trend of the two-photon channel follows
closely to the one-photon dye signal channel as can be seen with the signal within the circled
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portion. This is further evidence of a more specific correlation between the dye’s one-photon
fluorescence and two-photon fluorescence channels.

Figure 1-12 Images for ROI intensity studies of 2. a) One-photon fluorescence excitation at 561
nm. b) One-photon fluorescence excitation at 488 nm excitation. c) Two-photon fluorescence
excitation at 902 nm. Region of interests (ROIs) are color coordinated with ROI 1 being green,
ROI 2 purple, and ROI 3 orange. Scale bar 50 µm.
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Figure 1-13 Intensity spectra for the regions of interests shown in Figure 1-12. Red lined
spectrum in each of the spectra corresponds to Figure 1-12a intensities, green lined spectrum to
Figure 1-12b, and blue lined spectrum to Figure 1-12c. a) ROI 1 in green shows intensities at
that region through all three channels. b) ROI 2 in purple, and c) ROI 3 in orange.
1.5 Conclusion
A comprehensive linear and non-linear photophysical investigation into a new,
interesting BF2-β-diketonate dye is reported here with a considerable 2PA cross section. In vitro
studies for possible bioapplications using compound 2, with and without encapsulation with
Pluronics F127, show promising results for further consideration. Improved hydrophilicity for
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the individual compound or better control of encapsulation size for particles can be possible
subjects for future studies.
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CHAPTER 2. A NEW BODIPY-BASED WATER-SOLUBLE
FLUORESCENT PROBE FOR SELECTIVE MITOCHONDRIAL
TARGETING
2.1 Abstract
A totally water-soluble fluorescent mitochondrial targeting probe is reported. The probe
bears a BODIPY-based fluorophore, two triphenylphosphonium (TPP) groups as the
mitochondrial targeting moiety, and two PEG groups to increase its water solubility and reduce
its cytotoxicity. As a mitochondria-selective fluorescent probe, it exhibited many desirable
advantages, such as superior water solubility, high quantum yield, solvent independence, pH
insensitivity, good photostability, low cytotoxicity, and excellent mitochondrial targeting ability.
Confocal fluorescence microscopy colocalization experiments demonstrated that the probe
specifically localized in mitochondria within living cells.
2.2 Introduction
As a membrane-bound subcellular organelle, mitochondria are found in nearly all
eukaryotic cells that make up various forms of life including protists, fungi, plants, and
animals.65-66 The number of mitochondria in different types of cells varies in a wide range from
one to thousands. As powerhouses of eukaryotic cells, the most prominent roles that
mitochondria play are to generate most of the cells’ ATP and to regulate cellular metabolism. 67
Apart from supplying cellular energy, mitochondria also have some other functions and take part
in many physiologically important processes, such as calcium ion storage and signaling,
initiating cellular apoptosis, membrane potential regulation, steroid synthesis, certain heme
synthesis, producing most of the cellular reactive oxygen species, as well as the regulation of
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cellular proliferation and cell cycle.68-78 In addition, mitochondria have its own independent
mtDNA (mitochondrial DNA) despite that most cellular DNA is contained in cell nuclei.79
Due to the significant roles of mitochondria for life, mitochondrial damage and
dysfunction may lead to serious human diseases. It has been shown that mitochondria are
involved in certain diseases such as cardiac dysfunction, mitochondrial disorders, and autism.67,
80-81

Mitochondrial disorders are generally presented as multiple endocrinopathy, diabetes,

myopathy, and some other systemic diseases.81-82 Moreover, relationships between mitochondrial
change and aging process has been proposed for over 50 years.68,

83

It is still under debate

whether mitochondrial change is the cause of aging or just a characteristic of aging.
Although extensive efforts have been devoted to investigating mitochondrial biology,
people are still far from totally unveiling the mystery of mitochondria. A great number of basic
functions and activities of mitochondria and related mechanisms remain unclear, which is
hindered seriously by the lack of ideal techniques for tracking biological events of mitochondria.
Therefore, the development of an effective approach that is capable of targeting and
subsequently binding mitochondria to monitor their locations, movements, and even changes is
of great importance.
It has been widely accepted that fluorescence technique are among the most important
tools in the fields of modern bioanalysis and real-time bioimaging.84-85 In recent years, a myriad
of fluorescent probes have been developed for analyzing various biological analytes because of
the distinguished advantages of fluorescent probes including excellent sensitivity, non-invasive
property, and high spatial resolution.86-87 These desirable merits of fluorescent probes make it
possible to develop a fluorescent mitochondrial probe to achieve the goal of tracking biological
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events of mitochondria through observing changes in the number, subcellular localization, and
morphology of mitochondria. For such a probe, the following unique characteristics should be
possessed: (1) specific targeting to mitochondria, (2) high binding affinity to mitochondria, (3)
sufficient stability in cellular environment and photostability, (4) good solubility in water, (5)
high quantum yield in aqueous media, (6) desirable capability of being taken up by cells, and (7)
low cytotoxicity.
A variety of fluorescent probes for mitochondrial targeting have been explored. Some
of them have already been commercially available, such as rhodamine 123, TMRE
(tetramethylrhodamine ethyl ester), TMRM (tetramethylrhodamine methyl ester), MitoCapture,
JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide), DiOC6(3)
(3,3-dihexyloxacarbocyanine iodide), and MitoTracker series of compounds.88-89 Although these
fluorescent mitochondrial probes are widely used at present, none of them meet all the afforementioned requirements. For example, the selectivity of rhodamine 123 for mitochondrial
targeting is low.90 MitoCapture and JC-1 have dual emission spectra, which hinders multicolor
imaging in colocalization investigation.90-91 TMRE, TMRM, and DiOC6(3) inhibit mitochondrial
respiration, exhibiting high cytotoxicity.90, 92 MitoTracker probes based on cyanine fluorophore
suffer from photobleaching.90 As a result, applications of these probes are limited in some
respects and careful selection is necessary before using them. Therefore, a fluorescent
mitochondrial probe possessing all those desired properties is still in need. Herein, a BODIPYbased (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) fluorescent mitochondrial probe (3) bearing
two TPP groups and two long PEG (polyethylene glycol) chains is reported.
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2.2.1 BODIPY dyes
The BODIPY dye family has been studied extensively due to their many compelling
characteristics including intense absorption profile, sharp fluorescent emission peak, negligible
triplet-state formation, high fluorescence quantum yield, photochemical stability, insensitivity to
pH of the environment, stability to physiological conditions, and chemical robustness.48, 93 The
IUPAC numbering system for the BODIPY core is shown in Figure 2-1. The versatility of the
core can be shown by the possible modifications that can be applied to the core to tweak its
unique properties.

Figure 2-1 BODIPY core and positions for nomenclature.
Positions 1, 3, 5, and 7 have the ability to be alkylated, which could then consequently
lead to longer absorbing and emitting compounds by extension of the conjugation or addition of
donors.93 Furthermore, position 8 (also referred to as the meso position) when substituted shows
no consequence to the spectral profile of the core. It can however, if substituted with a phenyl,
have a negative effect to the quantum yield of the compound but then an increase in quantum
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yield if combined onto a 1, 7 substituted core. This observation is highly attributed to the
prevention of free rotation of the phenyl group, which ultimately reduces loss in non-radiative
processes.48 This position also allows the opportunity to modify the structure for various
applications such as ion sensing without much negative effect towards the core spectral profile.94
2.3 Materials and Methods
2.3.1 General Materials and Instruments
All reagents and solvents were purchased from commercial suppliers and used without
further purification. Flash column chromatography was performed on a CombiFlash® Rf+
automated flash chromatography using RediSep Rf Gold® normal-phase HP silica columns. 1H
and 13C NMR spectra were carried out in CDCl3 solution on a Bruker AVANCE spectrometer
(400 MHz). An Agilent 8453 spectrophotometer was used for UV-vis absorption spectra
measurements. Fluorescence emission spectra were measured with an FLS980 fluorescence
spectrometer equipped with a PMT (photomultiplier tube) detector. Fluorescence lifetime
determination was conducted with a tunable Ti:sapphire laser system (76 MHz repetition rate
and 220 fs pulse width) and a PicoHarp 300 time-correlated single-photon counting system (~80
ps time resolution). The pH values of samples were determined with an accumet® AB15 Basic
pH/mV benchtop meter. Confocal fluorescence microscopy images were recorded on a Leica
SP5 confocal laser microscope equipped with a HC PL APO 63x/1.20 water immersion
objective.
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2.3.2 Computational Methods
The structure of the fluorophore of 3 was optimized using the B3LYP method in the
GAUSSIAN09 program package with the D95* basis set. TD-DFT calculations were performed
with B3LYP, M06, and modified M05-QX functionals.95
2.3.3 Fluorescence Quantum Yields
Fluorescence quantum yields were calculated by using equation 1. The standard used
was rhodamine 6G in ethanol (ΦR = 0.94) as a reference.
2.3.4 Photostability Measurements
Photostability measurements were performed using a 532 nm diode laser as excitation.
A lens was used to expand the beam to irradiate the entire volume of the sample in a 1 mm path
length quartz cuvette. A standard power meter measured average excitation power before and
after each sample trials. After irradiation the absorption spectra were recorded at incremental
time intervals till a drop of no less than 15% in optical density was observed. The
photodecomposition quantum yield was calculated using the collected data and the following
equation:96
(
(

)
(

)⁄

)(

(6)

)

where η is the photodecomposition quantum yield, A1 and A0 are absorbance maximum at time
points t1 and t0, respectively, NA is Avogadro’s number, ε is the extinction coefficient (M−1·cm−1),
I is the intensity of laser (photon·cm-2·s-1), t1-t0 is the irradiation time (s).
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2.3.5 Synthesis
Synthesis of Compound 2C. To a mixture of 2A (17.6 g, 25 mmol), 2,4-dihydroxybenzaldehyde
(1.38 g, 10 mmol), K2CO3 (3.04 g, 22 mmol) was added 50 mL degased anhydrous DMF under
argon atmosphere. The reaction mixture was heated to 130 °C and stirred overnight. After
cooling to room temperature, the solvent was removed under reduced pressure. Then the residue
was added 100 mL CH2Cl2 and filtered. The filtrate was washed with brine (100 mL × 2). The
organic layer was dried over MgSO4, then filtered and condensed under vacuum. The crude
product was further purified by flash column chromatography using 3.0% methanol/CH2Cl2 as
eluent to give compound 2C as a colorless liquid (10.7 g, 89.0%). 1H NMR (400 MHz, CDCl3):
δ (ppm) 10.32 (s, 1H), 7.79 (d, J = 8.7 Hz, 1H), 6.55 (dd, J = 8.7, 2.2 Hz, 1H), 6.48 (d, J = 2.2
Hz, 1H), 4.18 (dd, J = 9.8, 5.8 Hz, 4H), 3.91 – 3.84 (m, 4H), 3.76 – 3.57 (m, 87H), 3.54 (dd, J =
6.1, 3.3 Hz, 4H), 3.37 (s, 6H).
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C NMR (101 MHz, CDCl3): δ (ppm) 188.26, 165.28, 162.92,

130.22, 119.30, 106.68, 99.55, 72.54, 71.94, 71.00, 70.87, 70.63, 70.61, 70.58, 70.52, 70.36,
69.46, 69.43, 68.25, 67.79, 61.72, 59.04.
Synthesis of Compound 2D. To a solution of 2C (6.01 g, 5.0 mmol) and 2,4-dimethylpyrrole
(1.05 g, 11.0 mmol) in 500 mL CH2Cl2 was added 5 drops of trifluoroacetic acid. The mixture
was stirred at room temperature overnight, then a mixture of 2,3-dichloro-5,6-dicyano-pbenzoquinone (1.36 g, 6.0 mmol) in 100 mL CH2Cl2 was added. The reaction mixture was stirred
continuously for another 4 h. After the addition of 30 mL triethylamine, 30 mL BF3·OEt2 was
added dropwise to the mixture. The mixture was kept stirring at room temperature overnight,
then filtered through a celite pad. The residue was washed with 200 mL CH2Cl2 and the
combined filtrate was rotary evaporated to dryness. The residue was dissolved in 300 mL CH2Cl2
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and the solution was washed with 300 mL 5% aqueous NaHCO3 solution followed with water
(300 mL × 2). The organic layer was dried over anhydrous MgSO4, filtered and then evaporated
in vacuo. The crude product was purified by flash column chromatography using 2.5%
methanol/CH2Cl2 as the eluent to give 2D as a dark red liquid (1.53 g, 21.5%). 1H NMR (400
MHz, CDCl3): δ (ppm) 6.98 (d, J = 8.2 Hz, 1H), 6.62 – 6.52 (m, 2H), 5.93 (s, 2H), 4.17 – 4.12
(m, 2H), 4.05 – 4.01 (m, 2H), 3.89 – 3.86 (m, 2H), 3.75 – 3.50 (m, 125H), 3.42 – 3.34 (m, 10H),
2.51 (s, 6H), 1.47 (s, 6H). 13C NMR (101 MHz, CDCl3): δ (ppm) 161.09, 156.72, 154.74, 142.85,
139.12, 132.12, 130.00, 120.78, 116.66, 106.32, 100.49, 72.46, 72.00, 71.06, 70.94, 70.59, 70.55,
70.43, 70.28, 69.80, 69.15, 69.09, 67.67, 61.65, 59.12, 14.64, 14.17.
Synthesis of Compound 2E. To a solution of compound 2D (1.42 g, 1.0 mmol) in 10 mL
anhydrous CH2Cl2 was added N-iodosuccinimide (NIS) (0.45 g, 2.0 mmol), and the resulting
mixture was stirred for 5 h in the dark at room temperature. Then the reaction mixture was
diluted with 20 mL CH2Cl2 and washed with brine (50 mL × 2). The organic layer was dried over
MgSO4, and concentrated under reduced pressure. The residue was purified by flash column
chromatography using 3.0% methanol/CH2Cl2 as the eluent to give 2E as a red liquid (1.19 g,
71.2%). 1H NMR (400 MHz, CDCl3): δ (ppm) 6.93 (d, J = 8.1 Hz, 1H), 6.64 – 6.56 (m, 2H),
4.19 – 4.15 (m, 2H), 4.06 – 4.02 (m, 2H), 3.90 – 3.88 (m, 2H), 3.73 – 3.52 (m, 132H), 3.40 –
3.31 (m, 10H), 2.60 (s, 6H), 1.50 (s, 6H). 13C NMR (101 MHz, CDCl3): δ (ppm) 161.53, 156.68,
156.02, 145.10, 139.17, 132.01, 129.82, 116.26, 106.56, 100.66, 85.17, 72.01, 71.08, 70.97,
70.63, 70.47, 69.77, 69.06, 67.77, 59.13, 16.62, 16.05.
Synthesis of Probe 3. To a mixture of compound 2E (1.67 g, 1.0 mmol), compound 2B (1.19 g,
3.0 mmol), CuI (0.038 g, 0.2 mmol), and Pd(PPh3)4 (0.12 g, 0.1 mmol) was added 10 mL
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degassed solvent mixture THF:triethylamine (4:1) under argon atmosphere. The resulting
mixture was heated to 45 °C and stirred for 16 h in the dark. After cooling to room temperature,
the solvent was removed under reduced pressure and the residue was extracted with
CH2Cl2/brine. The organic layer was dried over MgSO4, then filtered and condensed. The crude
mixture was purified by flash column chromatography using 10% methanol/CH2Cl2 to provide 3
as a purple liquid (1.25 g, 56.6%). 1H NMR (400 MHz, CDCl3): δ (ppm) 7.81 – 7.55 (m, 30H),
6.83 (d, J = 8.3 Hz, 1H), 6.63 – 6.52 (m, 2H), 4.15 (s, 2H), 4.10 – 3.99 (m, 6H), 3.86 (t, J = 4.4
Hz, 2H), 3.80 – 3.35 (m, 102H), 3.34 – 3.23 (m, 10H), 2.49 (s, 4H), 2.26 (s, 6H), 1.28 (s, 6H).
13

C NMR (101 MHz, CDCl3): δ (ppm) 161.37, 157.12, 156.28, 144.03, 140.25, 135.03, 135.00,

133.90, 133.80, 133.75, 133.65, 131.27, 130.63, 130.58, 130.50, 130.45, 130.39, 130.26, 129.38,
118.24, 117.38, 115.33, 114.75, 106.77, 100.71, 92.92, 92.84, 71.71, 70.65, 70.22, 70.11, 69.56,
68.96, 68.81, 67.64, 58.90, 23.27, 22.76, 22.55, 14.19, 14.15, 13.40, 12.91.
2.3.6 Cytotoxicity Assay
Viability assays for probe 1 in HCT-116 cells were conducted via MTS assay. Cells were
cultured in Costar 96 well plates for two days. They were then incubated with varying
concentrations of 3 for one day. Next, 20 µL of CellTiter 96 Aqueous One solution was added
into each well, followed by further incubation for additional 2 h. Absorption at 490 nm for the
corresponding MTS-formazan was then measured with a SpectraMax M5 Microplate Reader.
These measurements were then compared with those of control experiments in which wells were
incubated in the absence of probe 3 to calculate relative cell viability.
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2.3.7 Cell Culture for Imaging
HCT-116 cells were cultured in RPMI cell medium supplemented with 10% fetal bovine serum
and 1% penicillin and streptomycin at 37 °C and 5% CO2. Cells were then seeded onto 20 mm
glass slides which were functionalized with 4% poly-d-lysine, followed by incubation for two
days so as to get an enough amount of cells to be imaged. After that, cells were incubated with a
solution of probe 3 and MTG for 2 h and then confocal fluorescence emission images and the
phase contrast image of cells were taken. When taking images, laser lines of 561 nm and 458 nm
were used to excite probe 3 and MTG, respectively. Detection ranges for probe 3 and MTG
were from 571-700 nm and 470-540 nm, respectively. After obtaining the images, colocalization
of probe 3 and MTG was analyzed through comparing the fluorescence intensity profiles of the
images of two dyes on the same spot.
2.4 Results and Discussion
2.4.1 Molecular Design and Calculations
As a well-known and widely used fluorophore, BODIPY has many compelling
characteristics including intense absorption profile, sharp fluorescent emission peak, negligible
triplet-state formation, high fluorescence quantum yield, photochemical stability, insensitivity to
pH of the environment, stability to physiological conditions, and chemical robustness.48,
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Therefore, a BODIPY platform is employed as the fluorophore of probe 3. Quantum chemical
calculations were performed on the structure of the fluorophore of 3 using the B3LYP method.
Figure 2-2 shows the optimized structure, and frontier molecular orbitals plotted against their
respective energies. The calculated absorption spectra resulting from the TD-DFT calculations
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show an absorption band at circa 455 nm corresponding to the HOMO  LUMO excitation
(Figure 2-2).

LUMO+
2
LUMO+
1

LUMO

HOMO
HOMO1
HOMO2

Figure 2-2 Optimized structure (left), and frontier molecular orbitals plotted against their
respective energies (right) for fluorophore 3.

Figure 2-3 Calculated absorption spectra for fluorophore 3 using the B3LYP (black), M06
(green), and M05-QX (blue) functionals.
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In the molecular design of probe 3, TPP groups are proposed to function as the
mitochondrial targeting units. TPP has been demonstrated to be a highly effective mitochondrial
targeting functional group and has been extensively utilized to selectively deliver
pharmacophores, probes, and antioxidants to mitochondria within cells since the late 1960s.88, 97104

In probe 3, two TPP groups are attached to the BODIPY fluorophore in order to increase its

selectivity towards mitochondria. Moreover, the two TPP groups are supposed to anchor
mitochondria like a fork, as illustrated in Scheme 2-1, and thusly strengthen the binding affinity
of probe 3 to mitochondria. The highly hydrophilic PEG chains of 3 are designed to improve its
water solubility. In addition, they can also help to reduce the cytotoxicity of probe 3, since PEG
moieties are biocompatible and have been widely used in foods, pharmaceutics, medicines, and
cosmetics.105-108

Scheme 2-1 Schematic illustration of the design of probe 3.
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Scheme 2-1 shows the designed mitochondrial targeting and signaling process of probe
3. The structure of 3 can be divided into two parts, the hydrophobic (including the BODIPY
fluorophore and TPP groups) and the hydrophilic moieties (PEG chains). In aqueous
environment, probe 3 behaves like a surfactant molecule, with the hydrophobic unit wrapped by
the long PEG chains. This behavior can make it easier to be taken up by cells for the probe as a
whole, because PEGs are capable of freely passing through cell membranes. It is known that the
accumulation of TPP within mitochondria is due to its positive charge and lipophilicity. 103-104
Therefore, when reaching mitochondria inside cells, the lipophilic TPP cations bind to the
negatively charged mitochondrial membranes, with the hydrophilic PEG chains spreading
outside of mitochondria. Upon excitation with appropriate light source, the BODIPY fluorophore
will emit fluorescence, facilitating visualization of mitochondria.
There is one more thing worth mentioning for the design of probe 3. Besides increasing
water solubility and reducing cytotoxicity of probe 3, the introduction of PEG groups contributes
another benefit to the function of 3 as a fluorescent probe. As demonstrated in Scheme 2-2, in a
BODIPY derivative with a phenyl group at the meso-position of the BODIPY core, the single
bond connecting the phenyl group and the BODIPY core can freely rotate, which results in
fluorescence quenching, coming from the nonradiative decay.109-111 Accordingly, the fluorescence
quantum yield should be enhanced when the free rotation of the meso-phenyl group is restricted
so as to prevent nonradiactive decay.112 In probe 3, one of the two long PEG chains is introduced
to the 7-position of the meso-phenyl group (Scheme 2-2). The sterical hindrance between the
bulky PEG group at 7-position and the methyl group at 1-position is supposed to prevent the
meso-phenyl group from freely rotating and consequently increase the fluorescence quantum
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yield of probe 3. The results of B3LYP calculations show that the meso-phenyl group is locked in
a perpendicular plane to the BODIPY core (Figure 2-2).

Scheme 2-2 Structures of BODIPY and probe 3.
2.4.2 Preparation of Probe 3
As shown in Scheme 2-2, the synthesis of probe 3 began with PEG 550, which was
used to prepare compound 2A according to a literature procedure,113 and 4-bromo-1-butyne,
which reacted with triphenylphosphine to prepare 2B following a reported procedure.114 Then
compound 2A was reacted with 2,4-dihydroxybenzaldehyde in the presence of K2CO3 to produce
2C in DMF. Compound 2D was synthesized via a condensation reaction of 2C with 2,4dimethylpyrrole in the presence of a catalytic amount of trifluoroacetic acid (TFA) at room
temperature, followed by an oxidation reaction with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone
(DDQ) and a subsequent chelation reaction with BF3·OEt2 in the presence of triethylamine
(TEA). Iodination of 2D with N-iodosuccinimide (NIS) in the dark afforded 2E as a red liquid.
Sonogashira coupling reaction was performed between 2E and 2B with Pd(PPh3)4 and CuI as
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catalysts in a solvent mixture THF:TEA (4:1) to provide the target product (3) as a purple liquid
in 57% yield.
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Scheme 2-3 Synthetic route of probe 3. Reagents and conditions: (a) p-toluenesulfonyl chloride,
NaOH, THF:H2O (1:1), 5 °C, 2 h; (b) ACN (acetonitrile), 80 °C, 3 d; (c) K2CO3, DMF, 130 °C,
overnight; (d) 2,4-dimethylpyrrole, TFA, DCM, room temperature, overnight; then DDQ, 4 h;
then TEA, BF3·OEt2, overnight; (e) NIS, DCM, in the dark, room temperature, 5 h; (f)
Pd(PPh3)4, CuI, THF:TEA (4:1), in the dark, 45 °C, 16 h.
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2.4.3 Absorption and Fluorescence Emission Spectroscopy
The photophysical properties of probe 3 were examined systematically by UV-vis
absorption and fluorescence emission spectroscopy. Initially, measurements of absorption and
fluorescence emission of 3 were carried out in solvents including DCM, THF, ACN, DMSO, and
H2O. Table 2 shows the photophysical properties of 3 in those solvents. UV-vis absorption and
fluorescence emission spectra of 3 in different solvents are presented in Figure 2-4. The
maximum wavelengths of absorption and emission spectra of 3 in five solvents are all about 552
nm and 573 nm, respectively, resulting in Stokes shifts around 20 nm. The consistent
performances of probe 3 in different solvents indicate that it is resistant to solvent effects.

Figure 2-4 UV-vis absorption (solid lines) and fluorescence emission (dashed lines) spectra of
probe 3 in different solvents.
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Fluorescence quantum yields and lifetimes of 3 in five solvents were also investigated.
As shown in Table 2, the fluorescence quantum yield value in ACN was determined to be as
high as 0.93, which is the highest among the five. In agreement with that, the longest
fluorescence lifetime, 5.47 ns, was also found in ACN. The picosecond time resolved
fluorescence decay profiles of 3 in different solvents are displayed in Figure 2-5. In water, the
fluorescence quantum yield is 0.59 and the lifetime value is 5.18 ns, which are both desirable for
fluorescence emission microscopy. It is noteworthy to mention that a fluorescent dye with both
very good water solubility and such a high quantum yield is rather rare.

Figure 2-5 Picosecond time resolved fluorescence decay profiles of probe 3 in different solvents.
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Table 2 Photophysical properties of 3 in DCM, THF, ACN, DMSO, and H2O: Absorption (λAbs),
Fluorescence Emission (λEm), Extinction Coefficient (ε), Stoke Shift (∆λ), Fluorescence
Quantum Yield (ФFL),a and Fluorescence Lifetime (τ)
DCM

THF

ACN

DMSO

H2O

λAbs (nm)

552 ± 1

555 ± 1

550 ± 1

555 ± 1

552 ± 1

λEm (nm)

574 ± 1

573 ± 1

567 ± 1

573 ± 1

573 ± 1

∆λ (nm)

22 ± 2

18 ± 2

17 ± 2

18 ± 2

21 ± 2

ε (M-1·cm-1)

5.4 × 104

6.4 × 104

13.3 × 104

11.4 × 104

1.1 × 104

ФFL

0.89 ± 0.09

0.57 ± 0.06

0.93 ± 0.09

0.75 ± 0.08

0.59 ± 0.06

τ (ns)

4.85

3.99

5.47

4.82

5.18

aFluorescence quantum yields were calculated relative to rhodamine 6G as the reference
standard in ethanol (ΦR = 0.94).

2.4.4 pH Insensitivity and Photostability
To further evaluate the qualification of probe 3 being used in biological environment,
its sensitivity to pH and photostability were examined. Figures 2-6a and 2-6b show the
absorption and fluorescence emission spectra of 3 at different pHs respectively. Apparently, in
the pH range of 1-13, no considerable difference was observed in either the absorption or the
emission spectra of 3, which suggests that probe 3 is insensitive to pH. On the other hand,
photodecomposition experiments were performed to study the photostability of the probe. Figure
2-6c exhibits the absorption spectra of 3 at different time point in a process of continuous
irradiation with a 532 nm diode laser. According to the equation shown in Experimental Section,
the photodecomposition quantum yield (η) of the dye was calculated to be 5.29 × 10-6, indicating
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the good photostability of 3. The results achieved from pH tests and photodecomposition
experiments strengthen the potency of the dye as a fluorescent mitochondrial-targeting probe.

Figure 2-6 pH insensitivity and photostability of probe 3: a) absorption spectra of 3 at different
pHs, from pH1 to pH13; b) fluorescence emisson spectra of 3 at different pHs, from pH1 to
pH13; c) absorption spectra of 3 after continuous irradiation with a 532 nm diode laser.
2.4.5 Cytotoxicity of Probe 3
The cytotoxicity of probe 3 was evaluated by a standard MTS assay.60 HCT-116 cells
were incubated with 1.56, 3.13, 6.25, 12.5, 25.0, 40.0, 50.0, 80.0, and 100 µM probe 3 for 24
hours. As shown in Figure 2-7, cell viability of HCT-116 cells incubated with up to 12.5 µM 3
was quite close to 100%, which indicates that probe 3 at that concentration exhibited almost no
level of cytotoxicity. Even higher concentrations of 3 were not able to bring about much damage
to cells. After incubation with 80.0 µM 3, around 80% of HCT-116 cells were still viable. All
these data demonstrate that the cytotoxicity of probe 3 is very low and it is suitable for being
applied to cell imaging experiments.
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Figure 2-7 Cell viability of HCT-116 cells incubated with different concentrations of 3.
2.4.6 Cell Imaging and Mitochondrial Targeting
Confocal fluorescence microscopy experiments were conducted in living HCT-116
cells to investigate the targeting ability of probe 3 for mitochondria. The intracellular distribution
patterns of 3 were observed through colocalization imaging experiments. Figure 2-8 displays the
confocal fluorescence images (images a and b) and the phase contrast image (image c) of cells
after incubation with both probe 3 and MitoTracker Green FM (MTG), a commercially available
mitochondrial dye, at the same time. Image a shows the fluorescence emission captured with 561
nm excitation for 3, and image b exhibits that collected with 458 nm excitation for MTG.
Detection ranges and excitation wavelengths were carefully chosen to avoid unwanted crosstalk
between the fluorescence signals of the two dyes because their spectra partially overlap.
Fluorescence detection for the signal of MTG was collected from 470 nm to 540 nm to prevent
any possible collection of the fluorescence emission of 3. A 561 nm excitation wavelength was
used to excit 3 in order to avoid exciting MTG and consequently fluorescence emission signal
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was collected between 571-800 nm. Image d is the overlay of images a and b. The overlayed
image displays that the fluorescence of 3 overlapped quite well with that of MTG, indicating that
probe 3 specifically localized in mitochondria within living cells.
Figure 2-8e shows the detailed fluorescence intensity profiles of a linear region across
an entire cell. The two curves (red and green) demonstrate the location and normalized intensity
of fluorescence emitted by two dyes. The excellent overlap between the two curves further
confirms the mitochondrial targeting ability of 3. In addition, the phase contrast image showed
that those cells were still in healthy conditions after the fluorescence imaging experiments, which
is in good agreement with the results obtained from the cell viability tests. These results indicate
that probe 3 is capable of selectively targeting mitochondria within living cells without inducing
considerable damages to cells.
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Figure 2-8 Confocal fluorescence images of HCT-116 cells after co-incubated with probe 3 and
MTG: a) image from probe 3 with excitation of 561 nm; b) image from MTG with excitation of
458 nm; c) the phase contrast image of cells; d) the overlay of images a and b; e) the
fluorescence intensity profile of the region marked with a short bar (being pointed by the yellow
arrow) on images a, b, and d. The scale bar is 50 µm.
2.5 Conclusion
In summary, a new mitochondrial targeting fluorescent probe (3) was designed and
synthesized. Probe 3 is composed of three moieties, a BODIPY platform working as the
fluorophore, two TPP groups serving as mitochondrial targeting moieties, and two PEG groups
to increase its water solubility, reduce cytotoxicity, and restrict intramoleculer rotation to
increase fluorescence quantum yield. Results obtained from photophysical characterization
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experiments, cell viability tests, and confocal fluorescence microscopy experiments reveal that
probe 3 possesses nearly all the desired properties for a fluorescent mitochondrial probe,
including superior water solubility, high quantum yield, solvent independence, pH insensitivity,
good photostability, low cytotoxicity, and excellent mitochondrial targeting ability.
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CHAPTER 3. SYNTHESIS AND CHARACTERIZATION OF DIATRIZOIC
ACID DERIVATIVES AND NANOPARTICLE MODEL FOR X-RAY
COMPUTED TOMOGRAPHY TARGETED IMAGING
3.1 Abstract
Various radiographic diagnostic techniques rely on using X-ray contrast media containing
an X-ray contrast agent for the diagnosis and prognosis of tumors and other diseases. Among
common contrast agents (CAs), diatrizoic acid (DA) has shown improved biocompatibility and
contrast enhancement in numerous studies. Driven by these reports and the often cumbersome
syntheses of targeted DA derivatives, we disclose a simple and scalable protocol for the
preparation of maleimide-terminated DA derivative (DA-Mal) that can be feasibly conjugated to
thiol-containing peptides and other targeting biomolecules for possible application in X-ray
computed tomography (CT) targeted imaging. In addition, an elaborate and highly reproducible
procedure for the preparation of DA-conjugated silica nanoparticles (SiNP) having free
maleimide moieties that are designed as handles for further conjugation are described herein.
Characterization of both DA-Mal and DA-SiNP was accomplished using transmission electron
microscopy (TEM) as well as X-ray attenuation. TEM was able to show particle sizes from 100300 nm and confirm the conjugation of contrast agent by appearance of indicative iodine signal
by electron diffusional spectroscopy (EDS). X-ray enhancement experiments of the NP model
also shows some potential against the unconjugated model by showing a slightly higher
Hounsfield (Hu) signal to iodine concentration.
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3.2 Introduction
X-ray computed tomography (CT) is used as a diagnostic and noninvasive tool in imaging
internal structures of biological samples that offers a faster and more inexpensive means to
characterize physiological abnormalities when compared to magnetic resonance imaging (MRI)
and positron-emission tomography (PET). As a result of the intrinsic properties of CT, which
relies on the differences in electron densities, especially in cases of bone and body cavity
imaging, acquired images are more resolved as compared to other techniques X-ray CT imaging
requires the use of contrast agents that show subtle changes in soft tissue,115 hence resulting in
better imaging of internal vasculature and other organs. Among commonly used contrast agents,
diatrizoic acid (DA)116 has been used as a standard contrast agent in numerous studies for
contrast enhancement such as for macrophages117-118, gastrointestinal119-121, lungs122-123 and
others. This triiodoaryl compound contains two amide functional groups that enable improved
biocompatibility, and a carboxyl group that acts as a possible handle for functionalization with
targeting molecules.
Toward facilitating the use of DA for conjugation to targeting moieties, the preparation and
characterization of silica nanoparticles (SiNP) bearing amine functionalities on their surface to
anchor DA are also described here. In that regard, it was shown that the introduction of amide
linkers by conjugation of amines to the -COOH group of DA is somewhat inefficient, perhaps
due to the steric hindrance arising from the o-iodo substituents. Particularly, Guo et al.124
attempted to covalently and ionically bind DA to, as well as encapsulate DA within dendrimerentrapped gold nanoparticles showing the covalently bonded amount to be poorest, while
Parkesh et al.125 were unable to produce the condensation product of [(4-
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aminophenyl)ethoxycarbonylmethylamino]acetic acid ethyl ester with DA. However, the steric
hindrance resulting from the o-iodo substituents on the benzene ring has a lesser effect when –
COO- is alkylated with alkylhalides as indicated by the considerably high yields of reported DA
derivatives.121, 126
Prompted by these finding, we devised a scalable, efficient, and simple protocol for the
functionalization of DA with maleimide (DA-Mal) that allows for the swift conjugation of free
thiol-containing targeting proteins to the contrast agent under study. In a similar fashion, Nhydroxysuccinamide-terminated DA (DA-NHS) was prepared by employing the good
nucleophilic nature of DA–COOH group and 6-bromohexanoic acid to afford a less encumbered
–COOH that is easily conjugated with NHS. Following this, as mentioned before, the amineterminated SiNPs can then bind DA through an amide bond formation using the NHS group of
DA-NHS functionalized SiNPs.
3.3 Materials and Methods
3.3.1 Synthesis
6-(3,5-Diacetamido-2,4,6-triiodobenzoyloxy)hexanoic acid (3A). Sodium diatrizoate (1.152 g ,
1.812 mmol) was mixed with 6-bromohexanoic acid (0.439 g, 2.251 mmol) in 20 mL of DMF
and 200 µL of triethylamine. The solution was heated to 110 °C and reacted overnight. The
mixture appeared cloudy at first but slowly cleared when heated. Afterwards the reaction was
cooled to room temperature the reaction product was precipitated by pouring into excess diethyl
ether. The precipitate was filtered and washed with additional ether followed by DCM. The
solid was then dried under high vacuum to yield compound 3A (1.189 g, 1.633 mmol, 90%). 1H
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NMR (400 MHz, DMSO-d6) δ 10.01 (d, J = 34.7 Hz, 2H), 4.34 – 4.21 (m, 2H), 3.48 – 3.21 (m,
1H), 2.22 (t, J = 7.3 Hz, 2H), 2.02 (d, J = 1.0 Hz, 6H), 1.73 (p, J = 6.6 Hz, 2H), 1.60 – 1.49 (m,
2H), 1.44 (q, J = 8.1 Hz, 2H). 13C NMR (101 MHz, DMSO) δ 175.15, 168.60, 168.59, 147.80,
145.21, 97.91, 66.77, 34.30, 28.30, 25.89, 24.85, 23.73.
6-(3,5-Diacetamido-2,4,6-triiodobenzoyloxy)hexanoate N-succinimidyl ester (4). Compound
3A (1.311 g, 1.801 mmol) was dissolved in 8 mL of DMF and cooled to 0 °C with an ice bath.
Diisopropylcarbodiimide (DIC) was then added and allowed to stir for 10 min. The solution was
then allowed to warm to room temperature, and NHS (300 mg, 2.607 mmol) was added to the
solution and allowed to react with gentle heating overnight. Afterwards the reaction was poured
into excess ether and the precipitate formed was filtered and washed with DCM and excess
water, followed by drying under high vacuum to yield compound 4 (1.110 g, 1.346 mmol, 75%).
1

H NMR (400 MHz, DMSO) δ 10.11 – 9.88 (m, 2H), 4.29 (t, J = 6.3 Hz, 2H), 2.81 (s, 4H), 2.69

(t, J = 7.3 Hz, 2H), 2.02 (d, J = 0.8 Hz, 6H), 1.82 – 1.47 (m, 6H).

13

C NMR (101 MHz, DMSO)

δ 171.03, 169.69, 168.73, 168.60, 168.34, 147.81, 145.24, 109.49, 97.81, 97.73, 66.63, 30.83,
28.05, 26.24, 25.47, 24.59, 23.77, 23.73.
7-Oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic anhydride (3B). To a dried 250 mL roundbottom flask with a magnetic stir bar was added maleic anhydride (10.009 g, 102 mmol),
diethylether (20 mL), and furan (20 mL). The reaction was stirred at room temperature for 24 h.
The product precipitated out of solution and was collected via vacuum filtration and washed with
diethyl ether. The white solid product (15.24 g, 91.8 mmol, 90%) was used without further
purification. 1H NMR (400 MHz, Chloroform-d) δ 6.58 (t, J = 1.0 Hz, 2H), 5.46 (t, J = 1.0 Hz,
2H), 3.19 (s, 2H). 13C NMR (101 MHz, CDCl3) δ 137.33, 82.57, 49.07.
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N-(2-Hydroxyethyl)- 7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboximide (3C).To a dried 100
mL three-neck round-bottom flask with a magnetic stir bar and reflux condenser was added
compound 3B (10.0 g, 60.2 mmol) followed by dry methanol (20 mL) and ethanolamine(3.68 g,
60.2 mmol). The solution turned dark orange and was brought to reflux for 24 h. The flask was
cooled to room temperature, and after 2 h product began to crystallize. The mixture was further
cooled in a freezer overnight, and the precipitate was collected by vacuum filtration. The filtrate
volume was reduced by rotary evaporation and allowed to crystallize, and a second crop of
crystals was collected (6.88 g, 33.1 mmol, yield 55%). 1H NMR (400 MHz, DMSO-d6) δ 6.55 (t,
J = 0.9 Hz, 2H), 5.12 (t, J = 0.9 Hz, 2H), 4.78 (s, 1H), 3.52 – 3.35 (m, 4H), 2.92 (s, 2H). 13C
NMR (101 MHz, DMSO) δ 176.94, 136.92, 80.74, 57.73, 47.60, 41.07.
2-(1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-epoxyisoindol-2-yl)ethyl 4methylbenzenesulfonate (5). Compound 3C (4.00 g, 19.1 mmol) was added to a solution of
p-toluenesulfonyl chloride (3.65 g, 19.2 mmol) and pyridine (1.5 mL, 19.2 mmol) in dry DCM
(25 mL). The solution was stirred at room temperature for 8 h, and then poured into HCl solution
(1 N, 50 mL). The organic layer was collected and dried over Na2SO4. The solvent was
evaporated under reduced pressure and the resulting red crude mixture was digested in warm
ethyl ether and collected through filtration. The precipitate was recrystallized in boiling methanol
to afford the title compound as a fluffy white solid (5.60 g, 15.1 mmol, 79%). 1H NMR (400
MHz, CDCl3) δ 7.76 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 8.1 Hz, 2H), 6.51 (d, J = 0.8 Hz, 2H), 5.24
(t, J = 0.8 Hz, 2H), 4.19 (t, J = 5.5 Hz, 2H), 3.74 (t, J = 5.5 Hz, 2H), 2.85 (s, 2H), 2.44 (s, 3H).
13

C NMR (101 MHz, CDCl3) δ 176.09, 145.39, 136.88, 133.10, 130.24, 128.32, 81.21, 65.74,

47.89, 38.04, 21.99.
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2-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl 3,5-diacetamido-2,4,6-triiodobenzoate (6). A
solution of 5 (3.60 g, 10.0 mmol) and sodium 3,5-diacetamido-2,4,6-triiodobenzoate (6.40 g,
10.1 mmol) in DMSO (20 mL) was stirred at 90 ˚C for 8 h. After cooling down to room
temperature, the reaction mixture was poured into ice (300 g) and stirred for 30 min. The
precipitate was collected and washed with MeOH to afford the title compound as pale white
powder. Product then possibly contains a mixture of compound 6 and 3D, however further
heating of the product can deprotect any remaining furan .(4.10 g, 55%). 1H NMR (300 MHz,
DMSO-d6) δ 10.02 (d, J = 26.3 Hz, 2H), 7.01 (s, 2H), 4.53 – 4.27 (t, J = 6.0 Hz, 2H), 3.81 (t, J =
6.0 Hz, 2H), 2.00 (s, 6H). 13C NMR (75 MHz, DMSO-d6) δ 171.2, 168.3, 168.0, 147.0, 144.9,
135.2, 109.7, 97.5, 63.2, 23.4.
3.3.2 Preparation of DA and DA-PEG SiNP
4.5 µL of MeOH is initially mixed with 77 µL H2O and 5.5 µL of VTES with vigorous
stirring. To this solution 500 µL of 0.2 M NH4OH in MeOH is added dropwise for a period of
two hours. This solution was then allowed to stir for 24 h before the addition of 5 µL of APTS.
The solution was again allowed to stir for 24 h before the addition of 8.825 mg of compound 4 is
added for the DA NP and an additional 43.4 mg of Mal-PEG-NHS is added simultaneously for
DA-PEG NP along with two drops of 6N NaOH. The solution was allowed to stir for 24 h
before dialysis with a 10,000 MW Slide-A-Lyzer dialysis cassette purchased from Thermo
Scientific. Multiple rounds of 4 L ultrapure water was used for each sample prepared. These
samples were then filtered through a Puradisctm 1 uM polyethersulfone filter to remove any large
substances which may have precipitated during dialysis. Prepared nanoparticle solutions were
then stored in the fridge for further characterization.
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3.3.3 Characterization of prepared nanoparticles
An Agilent 8453 UV-vis spectrophotometer and a 10 mm path length quartz cuvette were
used to collect the absorption spectra of all samples. Extinction coefficient was performed by
dissolving a known concentration of compound 4 and using standard additions to calculate a
linear regression. A Zetasizer Nano-ZS90 by Malvern Instruments was used for the collection of
DLS size data. Transmission electron microscopy (TEM) was performed using a FEI Tecnai
F30 TEM equipped with an energy dispersive x-ray detector to perform electron diffusion
spectroscopy (EDS) experiments.
3.3.4 Micro computed tomography
For gross analysis of Hu enhancement, samples were scanned at an isotropic voxel size of
27.0 μm (Siemens Inveon PET/CT/SPECT scanner with cone beam X-ray source). The scans
were performed at 80 kVp voltage and 500 µA current with exposition time of 1000 ms per
projection. Total number of projections was 440 over 220 degree arc. The relative enhancement
of each sample was obtained from cylindrical 3D region of interests with effective volume
4.8 mm3.
3.4 Results and Dicussion
3.4.1 Synthesis and Preparation of Nanoparticle
The synthesis of DA-NHS 4 is depicted in Scheme 3-1. As discussed previously, the
good nucleophilic nature of DA-COOH group allows for the condensation of DA with 6bromohexanoic acid in DMF, in the presence of triethylamine (Et3N) that yield intermediate 3A.
Conversely, DA-NHS (4) is prepared by using N,N’-diisopropylcarbodiimide (DIC) as a
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coupling auxiliary, where the urea by-product thereof is easily washed off using organic solvents
such as DCM.

Scheme 3-1 Synthesis of DA-NHS (4).
The silica nanoparticles SiNP core was assembled following a modified Stöber method as
described in Scheme 3-2.127 Unlike tetraethyl orthosilicate (TEOS) whose SiNP would gelate in
solution after 48 h, vinyltriethoxysilane (VTES) was suitably employed to induce the formation
of SiNP, which have longer shelf life in solution. The slow addition of NH4OH into the initial
solution VTES in MeOH/H2O was implemented to improve the yield of SiNP having smaller
diameter.128 Upon formation of the SiNP core, the addition of (3-aminopropyl)triethoxysilane
(APTS) introduces a layer of free amines that engulf the SiNP exterior surface. Consequently, a
solution of NHS-PEG-Mal in DMSO was vigorously stirred in, resulting in functionalization of
the surface amines with Mal-PEG subunits. Dialysis followed by filtration of unconjugated
compounds and/or small flaky precipitate that was regarded as larger particles aggregate afforded
DA-PEG SiNP. The preparation of the unpegylated NP (DA-NP) followed the same procedure,
where no NHS-PEG-Mal was added.
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Scheme 3-2 Modified Stober method for preparation of CA conjugated VTES core nanoparticles
with maleimide functionalized PEGs.
3.4.2 Characterization and Imaging of DA Nanoparticles
A determination of particle sizes was achieved by performing dynamic light scattering on
the prepared nanoparticle solutions (DLS) using a Zetasizer Nano-ZS90. Results shown in
Figure 3-1 indicate that the diameters of unconjugated core particles range from 100 – 200 nm,
with the average mean size being approximately 141 nm. After anchoring compound 4 the size
distribution remains relatively the same, despite the formation of larger particles with a diameter
range of 105 – 300 nm.
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Figure 3-1 Number-averaged particle size distribution by light scattering for a) VTES core
nanoparticle, b) DA nanoparticle and c) maleimide-PEG functionalized DA nanoparticle.
This prompted us to further verify that such conjugation was achieved. Initially, the
examination of UV-vis measurements on compound 4 shows λabs at 238 nm that corresponds to
DA (Figure 3-2). The absorption profile of compound 4 was considered to estimate the
concentration of conjugated compound by using an experimental extinction coefficient (εmax) of
29 ± 7 ×10-3, M-1·cm-1 for compound 4 determined in MeOH. This value is within error of
reported extinction coefficient values for diatrizoic acid in water.116
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Figure 3-2 Absorption spectra for compound 3A and nanoparticle data in water (a) as well as 4
and core NP in MeOH (b). Extinction coefficient value of 29 ± 7 ×10-3, M-1·cm-1 was also
calculated based on the data collected for compound 4 in MeOH.
We further studied the prepared SiNP-DA using scanning transmission electron
microscopy (STEM) and transmission electron microscopy (TEM). Figure 3-3a is a STEM
image of the core NP. Prior to conjugation, the core particles show weak contrast due to the lack
of iodine. This poor contrast makes the core particle difficult to differentiate with the carbon
film of the TEM grid using conventional TEM. Figure 3-3a shows an approximately 100 nm
core particle, taken by STEM, as a white sphere upon the carbon film. For particles conjugated
to the PEG moiety and or CA the solution would be mixed together initially and filtered through
a 1 µm filter afterwards to obtain the desired size particles. Figure 3-3b and Figure 3-3c show
SiNP-DA as individual amorphous spherical particles with dark contrast due to the bonded
iodine.

The sizes of the particles measured here show a slight variation to those observed from

the DLS size data for the unPEGylated particle. This difference between the TEM measured size
data with that of the DLS size data was attributed to the hydrated and dehydrated behavior of the
particles. The PEGylated particle sizes measured using the TEM images, however, is consistent
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with the DLS reported data. It noteworthy that the TEM image of the particles, not shown here,
exhibits individual particles as well as clusters of particles, which could explain the sizes
reported by DLS.

Figure 3-3 Image a) shows the STEM image of the unfiltered VTES core nanoparticles
functionalized with APTS only. Image b) shows a 90 nm diameter nanoparticle functionalized
with DA contrast agent and image c) shows particles of 200 nm to 300 nm in diameters that were
functionalized with DA contrast agent and PEG-Mal.
In respect to the images taken in Figure 3-3, electron diffusion spectroscopy (EDS) was
also performed to characterize the atomic properties of the observed particles and is shown in
Figure 3-4. Figure 3-4a represents the EDS data taken from the core NP image from Figure 33a which indicates that (apart from some instrumental signal of Cu and Fe between 5 to 10 keV)
Si, O, and C are most abundant due to the presence of the SiNP. From Figure 3-4b and Figure
3-4c it clearly shows the appearance of iodine, which assures the bonding of compound 4 to the
nanoparticles.
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Figure 3-4 Electron diffusion spectroscopy (EDS) spectra with respect to nanoparticle image
data taken from Figure 3-3.
After characterization, the prepared particles were collected by lyphilization under high
vacuum as flaky white solids. Solubility of the unPEGylated particles proved difficult, as they
would not dissolve back into water. The PEGylated particle however showed good solubility
with water as well as into phosphate buffered saline (PBS). At this point the conjugation of the
PEG was confirmed by 1H NMR as a large peak at 3.50 ppm indicating the hydrogens that are
associated with the PEG chain (Figure 3-5).
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Figure 3-5 1H NMR of DA-PEG NP.
3.4.3 Maleimide Conjugated Free DA Model
A maleimide functionalized version of DA was also prepared (Scheme 3-3). The core
DA structure shows poor solubility to most non-polar organic solvents and only reasonable
solubility with polar solvents such as DMSO or DMF. Using these solvents it may sometimes
result poor yielding during the workup process. The reactions which are reported here are
simple, neat and high yielding. Compound 5 is first produced by forming compounds 3B and 3C
as reported.129-130 Mixture of compound 5 and DA salt in DMSO at 90 °C resulted nearly
simultaneous formation of compound 3D and deprotection of the volatile furan to give
compound 6. Purification of compound 6 included minor washes while the final deprotection
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required only heating. Compound 6 was later reacted with glutathione in a mixed solvent system
of DMSO/PBS 3:1 for use as a control system. This reaction occurs rapidly and was observed by
performing a small-scale reaction with deuterated DMSO and witnessing the rapid disappearance
of the maleimide bond at ~7.0 ppm. A nearly complete reaction was observed almost instantly
with a 1:1 ratio of DA to glutathione. When additional glutathione was added the peak at 7.0
ppm showed further decrease to nearly nothing. Conjugation to the glutathione also showed to
improve the solubility of the compound in water significantly which can lead us to believe that
the same would be true if conjugated to a larger protein.
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Scheme 3-3 Synthesis of Compound 6.
3.4.4 X-ray Contrast Enhancement Experiment
Finally, to evaluate both derivatives ability for X-ray absorption an analysis of
Hounsfield unit (Hu) enhancement performed by Micro CT was executed. Results were
calculated by taking images of prepared concentrated solutions placed within 20 uL wells of a
water phantom. A cylindrical region of interest (ROI) with a volume of 4.8 mm3 was taken and
the Hounsfield unit was calculated. The results are then plotted with HU versus iodine
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concentration and the plotted points are fitted to a linear regression. These results (Figure 3-6)
show the particles have similar enhancement capabilities as that of the free CA bound to a small
molecule based on increasing Iodine concentrations but the data is limited by solubility and
highest achievable concentrations (6.6 mM I for particle and 38.7 mM for free CA glucathione
conjugated).

Figure 3-6 X-ray enhancement results for a) DA-PEG NP and b) compound 3 with glutathione.
3.5 Conclusion
Herein we have reported the synthesis and characterization of two models using DA,
VTES silica nanoparticles conjugated to DA with PEG-maleimide, and free DA linked to
maleimide. The maleimide moiety is well known to have high reactivity to free thiols such as
those from a cysteine. This allows the possibility for the products reported here to be conjugated
to any targeting protein with a free cysteine group and be imaged by X-ray CT. The potential for
either model would be improved with greater solubility that my result by conjugation to larger
proteins. Optimization of the particle preparation procedure should also be investigated to
produce smaller particles that may also show improvement in solubility as well.
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CHAPTER 4. FUTURE WORKS
Future efforts related to chapter 3 are underway. Preliminary results involving mice are
being considered to observe contrast improvement for the vascular system. The developed
compounds in chapter 3 are also planned to be conjugated to a few targeting peptides. RGD47, 131
and CAR132-133 are two of the intended targeting proteins which are planned for conjugation with
the prepared contrast agents. Conjugation on to a free lysine off the RGD protein has been
reported.134 Extensive studies involving this small peptide has been reported regarding its ability
to specifically bind to αvβ3 integrin which is highly expressed in angiogenic vasculature.135 CAR
peptide however has not been studied as extensively with regards to RGD but is reported to show
the possible affinity to pulmonary arterial hypertension (PAH).132
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APPENDIX A: 1H AND 13C NMR SPECTRA OF NEW MOLECULES IN
CHAPTER 2
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1

H NMR spectrum (400 MHz) of 4 in CDCl3.
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C NMR spectrum (101 MHz) of 4 in CDCl3.
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H NMR spectrum (400 MHz) of 5 in CDCl3.
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C NMR spectrum (101 MHz) of 5 in CDCl3.
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H NMR spectrum (400 MHz) of 6 in CDCl3.
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C NMR spectrum (101 MHz) of 6 in CDCl3.
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H NMR spectrum (400 MHz) of 1 in CDCl3.
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C NMR spectrum (101 MHz) of 1 in CDCl3.
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APPENDIX B: 1H AND 13C NMR SPECTRA OF NEW MOLECULES IN
CHAPTER 3
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1

H NMR spectrum (400 MHz) of DA-NHS (4) in DMSO.
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C NMR spectrum (101 MHz) of DA-NHS (4) in DMSO.
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1

H NMR spectrum (400 MHz) of compound 5 in DCM.
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C NMR spectrum (101 MHz) of compound 5 in DCM.
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1

H NMR spectrum (400 MHz) of compound 3D in DMSO.
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C NMR spectrum (101 MHz) of compound 3D in DMSO.
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1

H NMR spectrum (400 MHz) of compound 6 in DMSO.
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13

C NMR spectrum (101 MHz) of compound 6 in DMSO.
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